For example, Song et al. showed in an aggressive HBc-expressing B16 melanoma model that the addition of Flt3L combined with RANTEs to an HBc prime-boost DNA vaccination regime resulted a strong antitumor response (40). The gene discussed is FLT3LG; the disease is melanoma.